Pituitary & hypothalamus

Exploring Brain Parenchymal Changes in Acromegaly: Focus on White Matter Hyperintensities

Clin Endocrinol (Oxf)Published Retrospective cohort study

Authors' conclusion

Several factors in acromegaly may affect brain structure, promoting WMH development, such as aging, disease duration, and hypertension. Therefore, in patients with acromegaly, we suggested the early management of cardiovascular comorbidities and regular radiological follow-up, not limited to the study of the pituitary gland. Future prospective studies are necessary to confirm our preliminary observations and to clarify the potential role of disease activity and treatment in WMH development.

Study context

Population
Patients with acromegaly who underwent gadolinium-enhanced brain MRI
Participants
37 patients
Exposure
Acromegaly patients with white matter hyperintensities (WMHs) vs without WMHs
  • WMHsn = 24
Outcome
Presence of WMHs in patients with acromegaly

Main finding

As reported in the abstract

Presence of WMHs

WMHs found

24 patients

64.9%

Higher lesion burden

9 patients

Observational data: associations, not effects.

Further findings

Age · older with WMHs

P = 0.023

Disease duration · longer with WMHs

P = 0.028

Comorbidities

Hypertension
22/37
Migraine
18/37

Association of WMHs with hypertension and migraine

Higher WMH burden significantly associated with hypertension
P = 0.05
No significant link between WMHs and migraine
P > 0.05

Original publication

Exploring Brain Parenchymal Changes in Acromegaly: Focus on White Matter Hyperintensities. Clin Endocrinol (Oxf). Published 20 November 2025. doi:10.1111/cen.70057

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.